ARCHIVES

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Mouse Strains Now Available From NCI

March 18, 1983

HHS News: Leavitt Confirmed As HHS Secretary.

January 28, 2005

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001